U.S. Cancer Treatment Market - Industry Trends and Forecast to 2029

U.S. Cancer Treatment Market - Industry Trends and Forecast to 2029

U.S. cancer treatment market is projected to register a substantial CAGR of 12.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029

Market Segmentation:

U.S. Cancer Treatment Market, By Cancer Type (Breast Cancer, Colorectal Cancer with Liver Metastases, Lung Carcinoma, Prostate Cancer, Ovarian Cancer, Head-And-Neck Cancer, Pancreatic Cancer, Glioblastoma, Renal Cell Carcinoma, Anaplastic Thyroid Carcinoma, Sarcoma, and Others), Treatment (Medication, Targeted Therapies, Radiotherapy, Surgery, and Others), Route of Administration (Injectable, Oral, and Others), End User (Hospitals, Specialty Clinics), Country (U.S.) - Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the U.S. cancer treatment market are:
• Presence of major market players
• Rising technological advancements
• Launch of FDA approved drugs

Market Players:

Some of the major companies dealing in the U.S. cancer treatment market are listed below:
• Bristol-Myers Squibb Company
• F. Hoffman La-Roche Ltd.
• Clegen
• AbbVie, Inc.
• Pfizer, Inc.
• Novartis AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.